Placental-mediated increased cytokine response to lipopolysaccharides: a potential mechanism for enhanced inflammation susceptibility of the preterm fetus. by Boles, Julie L et al.
UCLA
UCLA Previously Published Works
Title
Placental-mediated increased cytokine response to lipopolysaccharides: a potential 
mechanism for enhanced inflammation susceptibility of the preterm fetus.
Permalink
https://escholarship.org/uc/item/3jq7c8jg
Journal
Journal of inflammation research, 5(1)
ISSN
1178-7031
Authors
Boles, Julie L
Ross, Michael G
Beloosesky, Ron
et al.
Publication Date
2012
DOI
10.2147/JIR.S32108
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
© 2012 Boles et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article  
which permits unrestricted noncommercial use, provided the original work is properly cited.
Journal of Inflammation Research 2012:5 67–75
Journal of Inflammation Research
Placental-mediated increased cytokine response 
to lipopolysaccharides: a potential mechanism  
for enhanced inflammation susceptibility  
of the preterm fetus
Julie L Boles1
Michael G Ross1
Ron Beloosesky2
Mina Desai1
Louiza Belkacemi1
1Department of Obstetrics and 
Gynecology, Harbor-UCLA Medical 
Center, Los Angeles Biomedical 
Research Institute at Harbor-UCLA, 
David Geffen School of Medicine 
at UCLA, University of California, 
Los Angeles, Torrance, CA, USA; 
2Department of Obstetrics and 
Gynecology, Rambam Medical  
Center, Haifa, Israel
Correspondence: Louiza Belkacemi 
Department of Obstetrics and 
Gynecology, Harbor-UCLA Medical 
Center, Los Angeles Biomedical Research 
Institute at Harbor-UCLA, and David 
Geffen School of Medicine at UCLA, 
Torrance, CA, USA 
Tel +1 310 222 1962 
Fax +1 310 222 4132 
Email lbelkacemi@obgyn.humc.edu
Background: Cerebral palsy is a nonprogressive motor impairment syndrome that has no 
effective cure. The etiology of most cases of cerebral palsy remains unknown; however, recent 
epidemiologic data have demonstrated an association between fetal neurologic injury and 
infection/inflammation. Maternal infection/inflammation may be associated with the induction 
of placental cytokines that could result in increased fetal proinflammatory cytokine exposure, 
and development of neonatal neurologic injury. Therefore, we sought to explore the mechanism 
by which maternal infection may produce a placental inflammatory response. We specifically 
examined rat placental cytokine production and activation of the Toll-like receptor 4 (TLR4) 
pathway in response to lipopolysaccharide exposure at preterm and near-term gestational ages.
Methods: Preterm (e16) or near-term (e20) placental explants from pregnant rats were 
treated with 0, 1, or 10 µg/mL lipopolysaccharide. Explant integrity was assessed by lactate 
dehydrogenase assay. Interleukin-6 and tumor necrosis alpha levels were determined using 
enzyme-linked immunosorbent assay kits. TLR4 and phosphorylated nuclear factor kappa 
light chain enhancer of activated B cells (NFκB) protein expression levels were determined 
by Western blot analysis.
Results: At both e16 and e20, lactate dehydrogenase levels were unchanged by treatment 
with lipopolysaccharide. After exposure to lipopolysaccharide, the release of interleukin-6 
and tumor necrosis alpha from e16 placental explants increased by 4-fold and 8–9-fold, 
respectively (P , 0.05 versus vehicle). Conversely, interleukin-6 release from e20 explants 
was not significantly different compared with vehicle, and tumor necrosis alpha release 
was only 2-fold higher (P , 0.05 versus vehicle) following exposure to lipopolysaccharide. 
Phosphorylated NFκB protein expression was significantly increased in the nuclear fraction 
from placental explants exposed to lipopolysaccharide at both e16 and e20, although TLR4 
protein expression was unaffected.
Conclusion: Lipopolysaccharide induces higher interleukin-6 and tumor necrosis alpha 
expression at e16 versus e20, suggesting that preterm placentas may have a greater placental 
cytokine response to lipopolysaccharide infection. Furthermore, increased phosphorylated NFκB 
indicates that placental cytokine induction may occur by activation of the TLR4 pathway.
Keywords: cytokines, lipopolysaccharide, NFκB, placenta, rat pregnancy
Introduction
Cerebral palsy is a group of nonprogressive motor impairment syndromes that manifest 
during fetal or early postnatal life. Although cerebral palsy was previously attributed to 
perinatal hypoxia, this accounts for only a small percentage of cerebral palsy infants. 
Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
67
O R I G I n A L  R e s e A R C H
open access to scientific and medical research
Open Access Full Text Article
http://dx.doi.org/10.2147/JIR.S32108
Journal of Inflammation Research 2012:5
Epidemiological data have established that fetal or intra-
amniotic infections are associated with induction of 
fetal proinflammatory cytokines and the development of 
neurologic injury1 in preterm and near-term infants.2–5 
Despite these findings, the majority of cerebral palsy is still 
unexplained by either fetal infection or hypoxia.6,7
Whereas clinically significant fetal infection is uncommon, 
maternal infections (eg, pyelonephritis) occur both antepartum 
and intrapartum. Maternal infection/inflammation has been 
associated with fetal brain injury and offspring cerebral 
palsy. Maternal urinary tract infection increases the risk of 
cerebral palsy8,9 and this effect may be more significant when 
the exposure occurs at a preterm gestation.
Several mechanisms associate maternal infection with 
fetal inflammation. Direct transfer of bacteria may occur 
from the maternal bloodstream across the placenta into 
the fetal circulation. Early investigations showed that 
Gram-negative lipopolysaccharide does not cross human 
chorioamniotic membranes in vitro; however, in vivo 
studies have been contradictory. A low dose of iodinated 
lipopolysaccharide injected into mice is not detected in 
fetal tissues,10 but at significantly higher doses, iodinated 
tracer is detected in both the placenta and fetal tissues.11 
Alternatively, direct transplacental transfer of maternal 
cytokines may occur across the human placenta. Although 
there does not appear to be any transfer of tumor necrosis 
alpha (TNF-α), interleukin (IL)-1 or IL-8, the ability of 
IL-6 to cross the placenta remains controversial.12,13 In the 
absence of transplacental passage of lipopolysaccharide or 
cytokines, it has been proposed that the placenta acts as a 
site of cytokine production, following lipopolysaccharide 
activation, or maternally derived cytokines.
Studies from our laboratory indicate that simulated 
maternal infection with lipopolysaccharide evokes fetal 
systemic, amniotic, and placental inflammatory responses, and 
most importantly, increased expression of proinflammatory 
cytokines in the fetal brain.14 Toll-like receptors (TLR) 
are essential for an effective host cell response to 
lipopolysaccharide. Circulating lipopolysaccharide binding 
to membrane-bound TLR4 results in a series of kinase 
cascades that phosphorylate and translocate nuclear factor 
kappa light chain enhancer of activated B cells (NFκB) into 
the nucleus where it acts as a transcription factor stimulating 
production of proinflammatory cytokines by binding to 
promoter genes.15–17 Although an essential receptor for 
lipopolysaccharide signaling, TLR4 alone cannot confer 
lipopolysaccharide responsiveness. In addition to TLR4, 
TLR2 specificity also includes bacterial lipoproteins. 
Following bacterial infection, the current evidence suggests 
that TLR4 and TLR2 activate similar intracellular cascades. 
However, TLR4 may primarily promote a cytokine response, 
while TLR2 may result in cellular apoptosis.18 Because both 
TLR4 and TLR2 are likely to activate the same intracellular 
cascade, we focused primarily on the downstream effects 
of lipopolysaccharide binding (NFκB) as opposed to the 
different TLRs. The TLR4 pathway has been described in 
the human placenta, but not in the rat placenta. Human and 
rat placentas share important structural similarities, because 
both are hemochorial with comparable permeability to a 
range of hydrophilic compounds. Our laboratory and others 
have demonstrated the ability of the rat placenta to produce 
a cytokine response to maternal lipopolysaccharide.14,19
To explore the mechanism of maternal inflammation-
induced placental inflammatory response, we developed 
an ex vivo rat placental explant model, which includes 
both the junctional zone (site of hormone production) and 
the labyrinth zone (site of maternal-fetal exchange). This 
ex vivo explant model provides the opportunity to analyze the 
placental inflammatory response under multiple experimental 
conditions. The placental explant model maintains the 
structure of the placental tissues and keeps them in contact 
with their normal cellular environment, thereby facilitating 
physiological interactions. Although this model does not 
recreate in vivo homeostasis, it does allow greater control of 
the environment and provides for greater efficiency compared 
with animal models. Using this model, we examined 
TNF-α and IL-6 proinflammatory cytokine production in 
response to lipopolysaccharide. We specifically focused on 
these cytokines because previous in vivo studies from our 
laboratory demonstrated induction of TNF-α and IL-6 in 
maternal serum, amniotic fluid, chorioamnion, and placenta 
after maternal exposure to lipopolysaccharide but not 
IL-10 mRNA.14 Additionally, we investigated the mechanism 
by which placental proinflammatory cytokine release occurs, 
by establishing the presence of TLR4 and quantifying nuclear 
phosphorylated NFκB with and without lipopolysaccharide. 
We hypothesized that maternal lipopolysaccharide activates 
the placental TLR4 signaling pathway, which results in 
induction and release of proinflammatory cytokines into the 
fetal compartment.
Materials and methods
Animals
Eight-week-old first-time pregnant Sprague-Dawley rats 
(230–240 g) in body weight, (Charles River Laboratories 
Inc, Hollister, CA) were housed in a facility with constant 
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temperature and humidity, on a controlled 12-hour light/dark 
cycle and an ad libitum diet (controls) of standard labora-
tory chow (protein 23%, fat 4.5%, metabolizable energy 
3030 kcal/kg; Lab Diet 5001, Gray Summit, MO). All studies 
were carried out in accordance with the established guidelines 
of the ethics committee of the Los Angeles Biomedical 
Research Institute at Harbor-UCLA Medical Center, the 
American Association for Accreditation of Laboratory Care, 
and National Institute of Health guidelines.
Explant cultures
At embryonic day 16 (e16, n = 6), and embryonic day 20 
(e20, n = 7) the rats were sacrificed using an overdose of 4% 
isoflurane. Gestational sacs were removed from the uterus. 
Membranes attached to the placentas and deciduas were 
excised. The mid-portion of each placenta was divided into 
two explants (1 mm each) which were washed three times in 
phosphate-buffered saline. Two explants from each placenta 
were cultured in individual Costar Netwell supports (15 mm 
diameter, 74 µm mesh, Lowell, MA) in 2 mL of RPMI 
1640 medium (Invitrogen, Carlsbad, CA) supplemented 
with 5% heat-inactivated fetal bovine serum, and 100 µg/mL 
Mycosin (Invivogen, Carlsbad, CA) and incubated in a stan-
dard Sanyo incubator (5% CO
2
 in air, 37°C) for 12 hours. 
After 12 hours, the culture media were replaced with media 
including different concentrations of lipopolysaccharide 
(0, 1, and 10 µg/mL, Sigma-Aldrich, St Louis, MO). After 
30 minutes to 6 hours of incubation with lipopolysaccharide, 
the supernatants were collected, and stored at −80°C. The 
tissue explants were removed, weighed, and stored at −80°C. 
All explants and supernatants incubated with lipopolysac-
charide 0 µg/mL are referred to as vehicles.
Explant integrity assessment
Lactate dehydrogenase is a cytoplasmic enzyme20 which is 
rapidly released into cell culture medium upon membrane 
damage or cell lysis. Therefore, concentrations of lactate 
dehydrogenase in tissue explant and media assess placental 
membrane integrity during experiments. To assess membrane 
integrity in our explant cultures, we measured lactate 
dehydrogenase levels remaining in tissue explants and 
released into culture media after 6 hours of explant incubation 
(37°C) using a commercially available kit (Sigma-Aldrich). 
Briefly, tissue explants from e16 (n = 6) and e20 (n = 7) were 
homogenized in lactate dehydrogenase lysis solution using 
an ultrasonic cell disruptor (Ultrasonic Power Corporation, 
Freeport, IL), centrifuged, and the supernatants collected. 
Aliquots of homogenized tissue explants and culture 
supernatants were pipetted into separate wells of a 96-well 
plate with the lactate dehydrogenase mixture and incubated 
for 30 minutes. The reaction was terminated by addition of a 
1/10 volume of 1 N HCl to each well. Lactate dehydrogenase 
activity was determined by measuring the increase in 
absorbance at 490 nm. Each assay was run with a known 
standard curve of lactate dehydrogenase (Sigma-Aldrich) in 
duplicate, and each treatment was performed in triplicate.
Enzyme-linked immunosorbent assay 
determinations
We determined supernatant levels of IL-6 and TNF-α 
proinflammatory cytokines because they are clinically 
relevant in maternal infection-mediated cerebral palsy.21 We 
used commercially available enzyme-linked immunosorbent 
assay kits (R&D Systems, Minneapolis, MN) according to 
the manufacturer’s protocols. Briefly, for each cytokine, 
50 µL of assay diluent and 50 µL of supernatant were 
pipetted into separate wells precoated with specific antibody 
for either rat IL-6 or TNF-α and incubated for 2 hours at 
room temperature, following which the wells were rinsed 
five times with a wash buffer (provided with the kits). Next, 
an enzyme-linked antibody specific for rat IL-6 or TNF-α 
was added to the wells for an additional 2 hours. After five 
washes with the wash buffer, a substrate solution was added 
to each well for 30 minutes, following which a colored 
product representing the level of cytokine in the supernatant 
was obtained. Levels of IL-6 and TNF-α in the supernatants 
were quantified by optical density readings at 450 nm. Each 
assay was run with known standards and each treatment was 
performed in triplicate.
Subcellular fractionation
Total and nuclear fractions were isolated using the method 
described by Hikim et al.22 Next, e16 and e20 explants treated 
and not treated with lipopolysaccharide (n = 6 from each 
group) were sonicated on ice in buffer A [0.25 M sucrose, 
50 mM HEPES, 10 mM NaCl, 10 mM ethylenediamine tetra-
acetic acid, 2 mM DTT, 2 mM PMSF, one tablet protease 
inhibitor (complete mini tablets, Roche, Indianapolis, IL), 
and one tablet phosphatase inhibitor (PhosSTOP, Roche, 
Indianapolis, IL)], and incubated on ice for 15 minutes after 
which 100 µL of each lysate extract was transferred into a 
separate sterile Eppendorf tube (total protein fraction). The 
remaining crude homogenates were centrifuged at 1000 g 
for 10 minutes at 4°C to isolate the nuclear pellet which was 
redissolved in T-PER buffer (Thermo Scientific, Waltham, 
MA). The purity of the nuclear fractions was assessed 
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by Western blotting using antibodies to mitochondrial 
cytochrome c oxidase subunit IV (COXVI, Cell Signaling 
Technology, Danvers, MA), and lysine-specific demethylase 1 
(LSD1) (Cell Signaling Technology). Fractional protein con-
centrations were determined by bicinchoninic acid solution 
(Thermo Scientific). All fractions were frozen at −80°C.
TLR4 and phosphorylated nFκB Western 
blot analysis
Lipopolysaccharide treated or untreated total and nuclear 
protein lysates from e16 (55 µg) and e20 (55 µg) were 
separated on a 4%–12% gradient polyacrylamide gel 
(Invitrogen, Carlsbad, CA), and transferred to Immobilon-P 
membranes (BioRad, Hercules, CA). The membranes 
were incubated in a blocking solution (5% powdered 
nonfat milk in Tris buffered saline and 0.05% Tween-20 
[TBS-T]) at room temperature for one hour, and then in 
the same solution containing either TLR4 (1:2500; Cell 
Signaling Technology) or phosphorylated NFκB (1:2500; 
Cell Signaling Technology) primary antibody overnight 
at 4°C. Following three 10-minute washes in TBS-T, the 
membranes were incubated with a secondary goat antirabbit 
polyclonal antibody for TLR4 (1:3000; Vector Laboratories, 
Burlingame, CA) or a rabbit antimouse monoclonal antibody 
for NF-κB (1:2000; Cell Signaling Technology) labeled with 
horseradish peroxidase. After washes with TBS-T, the blots 
were developed using a chemiluminescence Western blotting 
kit (Denville, Metuchen, NJ), and subsequently exposed onto 
X-OMAT Kodak film (Eastman-Kodak, Rochester, NY). For 
equal loading, the blots were stripped and reprobed with 
either β-actin antibody (1:2000, BioRad) for total protein 
or LSD1 antibody (1:1000; Cell Signaling Technology) for 
nuclear protein.
Statistical analysis
Differences between 0, 1, and 10 µg/mL lipopolysaccharide-
treated groups were compared using one-way analysis 
of variance (IL-6, TNF-α, lactate dehydrogenase), and a 
two-tailed Student’s t-test (NFκB, TLR4) using SigmaStat 
(version 3.0; Systat Software Inc, Chicago, IL). Values 
were expressed as the mean ± standard error and considered 
statistically significant at P , 0.05.
Results
Explant integrity
Cell membrane integrity was assessed by comparing levels 
of lactate dehydrogenase in tissue and lactate dehydrogenase 
released into culture after 6 hours of treatment with and without 
lipopolysaccharide at e16 and e20. At e16, there was no significant 
difference in lactate dehydrogenase levels from tissue explants 
treated with 1 or 10 µg/mL lipopolysaccharide (2.2 ± 0.52 U and 
1.5 ± 0.37 U lactate dehydrogenase/mL, respectively) compared 
with vehicle (2.4 ± 0.73 U lactate dehydrogenase/mL, P = 0.52). 
Similarly, in culture supernatants from explants treated with 
1 or 10 µg/mL, levels of lactate dehydrogenase released into 
media (0.50 ± 0.06 and 0.36 ± 0.09 U lactate dehydrogenase/
mL, respectively) were comparable with those from vehicle 
(0.48 ± 0.08 U lactate dehydrogenase/mL, P = 0.36). 
Likewise, at e20, there was no significant difference in lactate 
dehydrogenase levels from tissue explants treated with 1 or 
10 µg/mL lipopolysaccharide (66.7 ± 15.9 U and 47.5 ± 6.4 
U lactate dehydrogenase/mL, respectively) compared with 
vehicle (51.3 ± 11.7 U lactate dehydrogenase/mL, P = 0.21). 
In culture supernatants from explants treated with 1 or 10 µg/
mL, the levels of lactate dehydrogenase released into culture 
media (5.6 ± 0.58 and 4.9 ± 0.55 U lactate dehydrogenase/mL 
respectively) were similar to those from the vehicle (3.9 ± 0.85 U 
lactate dehydrogenase/mL, P = 0.27).
Proinflammatory cytokine induction  
by lipopolysaccharide
At e16, explants exposed to lipopolysaccharide for 6 hours 
demonstrated a significant release in proinflammatory 
cytokines into media. Indeed, IL-6 release increased by 
4.4-fold following exposure to 1 µg/mL (Figure 1A, 
3845 ± 618 pg/mL/g tissue, P , 0.05), and by 4.9-fold after 
treatment with 10 µg/mL lipopolysaccharide (Figure 1A, 
4276 ± 475 pg/mL/g tissue, P , 0.05) compared with vehicle 
(1167 ± 338 pg/mL/g tissue). TNFα release was increased 
by 8.2-fold after exposure to 1 µg/mL lipopolysaccharide 
(Figure 1B, 755 ± 110 pg/mL/g tissue, P , 0.05) and 9.4-fold 
after 10 µg/mL lipopolysaccharide treatment (Figure 1B, 
869 ± 97 pg/mL/g tissue, P , 0.05) compared with the 
vehicle (92 ± 51 pg/mL/g tissue).
Conversely, at e20, proinflammatory cytokine IL-6 
levels released from explants exposed to 1 or 10 µg/mL 
lipopolysaccharide were not significantly different from 
the vehicle. Thus, IL-6 levels increased by 1.25-fold after 
exposure to 1 µg/mL lipopolysaccharide (Figure 1A, 
5303 ± 1118 pg/mL/g tissue), and by 1.75-fold after 10 µg/mL 
lipopolysaccharide (Figure 1A, 7371 ± 677 pg/mL/g tissue) 
compared with vehicle (4191 ± 568 pg/mL/g tissue, P = 0.62). 
Notably, e16 lipopolysaccharide-treated explants had higher 
IL-6 induction than e20 treated explants at each matched 
dose (1 and 10 µg/mL, P , 0.05). Unlike e16, TNF-α 
release at e20 was increased by only twofold compared 
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with the vehicle, although this difference was statistically 
significant for either 1 µg/mL (Figure 1B, 677 ± 87 pg/mL/g 
tissue, P , 0.05) or 10 µg/mL lipopolysaccharide exposure 
(Figure 1B, 674 ± 69 pg/mL/g tissue, P , 0.05) compared 
with the vehicle (324 ± 56 pg/mL/g tissue). Notably, e16 
lipopolysaccharide-treated explants showed higher TNFα 
induction than e20 treated explants at each matched dose 
(1 and 10 µg/mL, P , 0.05).
TLR4 and nFκB protein expression
For TLR4 and NFκB proteins, we detected one immunore-
active band of the expected molecular weight on Western 
blots of placental protein lysates from specimens with and 
without lipopolysaccharide at e16 and e20 (Figure 2A and B 
and Figure 3A and B). Densitometric analysis showed that 
1 µg/mL lipopolysaccharide did not change placental TLR4 
expression in the total protein lysates by 6 hours at e16 
 (Figure 2C) or by 2 hours at e20 (Figure 2C).
Upon activation, NFκB protein translocates from the 
cytoplasm to the nucleus where it activates proinflammatory 
genes. Our results demonstrated that nuclear phosphorylated 
NFκB increased in preterm placental explants after 
30 minutes of lipopolysaccharide exposure (Figure 3C, 
P , 0.05 versus vehicle). After 2 hours of lipopolysaccharide 
exposure, nuclear phosphorylated NFκB expression was still 
greater in the lipopolysaccharide-treated explants versus 
untreated controls, but was no longer significant (Figure 3C). 
Likewise, for near-term, phosphorylated NFκB was increased 
in the nucleus placental explants after 30 minutes of 
lipopolysaccharide exposure (Figure 3C, P , 0.05 versus 
vehicle). After 2 hours of lipopolysaccharide exposure, 
nuclear phosphorylated NFκB expression remained greater in 
the lipopolysaccharide-treated explants (Figure 3C, P , 0.05 
versus vehicle).
Discussion
In this study, exposure to lipopolysaccharide stimulated 
greater proinflammatory IL-6 and TNF-α cytokine release 
at e16 (preterm) compared with e20 (near-term) in rat 
placental explants. These findings suggest that the preterm 
placenta may be more susceptible to a lipopolysaccharide 
infection-induced placental cytokine response. The placental 
tissue exhibited constitutive TLR4 that was not influenced 
by lipopolysaccharide doses tested at either preterm or 
near-term gestation. After 30 minutes of lipopolysaccharide 
exposure, there was increased phosphorylated NFκB in the 
nucleus of the preterm and near-term explants, consistent 
with lipopolysaccharide-mediated activation of the TLR4 
pathway.
Clinically, studies have linked maternal infection/inflam-
mation with fetal brain injury and offspring cerebral palsy 
through fetal brain proinflammatory cytokines. The primary 
brain lesion associated with cerebral palsy is periventricu-
lar leukomalacia.23 Proinflammatory cytokines TNF-α and 
IL-6 are expressed in 88% of neonatal brain specimens with 
periventricular leukomalacia, compared with only 18% of 
cases without periventricular leukomalacia.24 Therefore, 
these cytokines may mediate the development of preterm 
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Figure 1 Fold change of pro-inflammatory cytokine interleukin (IL)-6 and tumor necrosis factor alpha (TnFα) released from preterm (e16) and near-term (e20) placental 
explants following lipopolysaccharide (LPs) treatments. explants were incubated with increasing concentrations of LPs (0 µg/mL, 1 µg/mL and 10 µg/mL) for 6 hours. 
enzyme-linked immunosorbent assay kits were used to determine supernatant levels of the cytokines IL-6 and TnFα. explants exposed to 1 µg/mL and 10 µg/mL LPs (A) 
demonstrated a significant release in IL-6. *P , 0.05 versus vehicle. Preterm (e16) LPs treated explants had higher IL-6 induction than e20 treated explants. +P , 0.05 versus 
e20 at each matched dose (1 and 10 µg/mL). Also explants exposed to either 1 µg/mL or 10 µg/mL LPs (B) demonstrated a significant release in TnFα. *P , 0.05 versus 
vehicle. Preterm (e16) LPs treated explants had higher TnFα induction than e20 treated explants. +P , 0.05 versus e20 at each matched dose (1 and 10 µg/mL). 
Note: Bar graphs represent means ± se of six (e16) or seven (e20) independent experiments. 
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neurologic injury because the less developed preterm brain 
may be more susceptible to damage.25
There are also many other potential mediators of this 
inflammatory response. In addition to proinflammatory 
cytokines, lipopolysaccharide and other bacterial components 
can induce the release or production of antimicrobial 
peptides, chemokines, prostaglandins, leukotrienes, and 
complement,26 which can result in the creation of reactive 
oxygen species.27 One human study found that cord blood 
samples from infants with cerebral palsy showed increased 
concentrations of epidermal growth factor and three 
chemokines (B lymphocyte chemoattractant, MCP-3, and 
monokine induced by interferon gamma) compared with 
controls.26 However, the majority of the clinical investigation 
into fetal neurologic injury and inflammatory response uses 
the release of proinflammatory cytokines as a marker for 
inflammation.27 Therefore, we focused this study on these 
proinflammatory cytokines.
We found a greater induction of IL-6 and TNF-α 
in the preterm placenta versus the near-term placenta 
regardless of the concentration of lipopolysaccharide used. 
Previously, we analyzed the in vivo maternal inflammatory 
response 6 hours after lipopolysaccharide injection at e16 
and e20,19,28,29, and the maternal proinflammatory cytokine 
response to lipopolysaccharide was more than twofold 
greater at e16 versus e20. This emphasizes that both maternal 
compartments and the placenta induce more proinflammatory 
cytokines at a preterm gestational age than at near-term. 
In contrast with lipopolysaccharide-stimulated responses, 
basal cytokines in the untreated placenta were increased at 
e20 versus e16. Interestingly, in human pregnancy, IL-1β and 
IL-8 expression were increased in third trimester amnion and 
in the choriodecidual tissue,30 and TNFα mRNA levels were 
significantly higher in the term placenta versus the preterm 
placenta in the absence of intrauterine infection.31 Thus, in 
both rat and human pregnancy, higher basal cytokines in 
term gestational tissues may play a role in establishment 
of labor.30
Consistent with our findings of an exaggerated cytokine 
response from preterm rat placentas, human preterm placen-
tas also showed an exaggerated inflammatory response.32 In 
particular, human placental cell cultures from noninfected 
preterm deliveries released significantly greater amounts of 
TNF-α and IL-1β than cultures from nonlaboring women at 
term.32 Compared with the term placenta, amnion cells and 
placental villous tissues from the preterm placenta showed 
a more pronounced cytokine response.33 Thus, induction 
of proinflammatory cytokines in the preterm placenta may 
0.8
TLR4
0 1 10LPS
(µg/mL)
β-actin
TLR4
0 µg
LPS/mL
1 µg
LPS/mL
β-actin
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0
e16 Gestational age e20
T
L
R
4/
β-
ac
ti
n
 (
ar
b
it
ra
ry
 u
n
it
)
C
A B
110 KD
42 KD
Figure 2 Toll-like receptor 4 expression from preterm (e16) and near-term (e20) placental explant protein lysates following LPs treatments. explants were incubated with 
or without LPs (0 µg/mL and 1 µg/mL) for 6 hours. Western blot (A and B) and densitometric analysis (C) showed that TLR4 protein expression was unaffected by LPs 
exposure at both gestational ages. P = 0.85 (e16) and p = 0.87 (e20) vs vehicle (0 µg/mL). 
Note: Bar graphs represent means ± standard error of six independent experiments. 
Abbreviations: LPS, lipopolysaccharide; TLR, toll-like receptor.
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
72
Boles et al
Journal of Inflammation Research 2012:5
+
∗
∗
∗
30 minutes 2 hours
30 minutes 2 hours
e16 e20
30 minutes 2 hours
30 minutes 2 hours
Time of LPS exposure
N
F
-κ
B
/L
S
D
1 
(a
rb
it
ra
ry
 u
n
it
)
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
NF-κB
LSD1
NF-kB
LSD1
0 µg
LPS/mL
1 µg
LPS/mL
65 KD
110 KD
LPS (µg/mL) 0 1 0 1 0 1 0 1
C
A B
Figure 3 Phosphorylated nuclear nF-kB protein expression from preterm (e16) and near-term (e20) placental explants following LPs treatments. explants were incubated 
with or without LPs (0 µg/mL and 1 µg/mL) for 30 minutes and 2 hours. Western blot (A and B) and densitometric analysis (C) showed that phosphorylated nuclear 
nF-κB was significantly increased in both e16 and e20 after exposure to LPs. +P = 0.064 vs untreated controls (0 µg/mL) (e16), and *P , 0.05 versus vehicle (0 µg/mL) 
(e16 and e20). 
Note: Bar graphs represent means ± SE of six independent experiments. 
Abbreviations: nF-κB, nuclear factor kappa-light-chain-enhancer of activated B cells; LPS, lipopolysaccharide.
result in increased fetal cytokine exposure and subsequent 
neurologic damage.
One proposed mechanism for the induction of proinflam-
matory cytokines in response to an infectious process is the 
binding of lipopolysaccharide to TLR4, that results in a series 
of kinase cascades that subsequently phosphorylate and trans-
locate NFκB into the nucleus where it acts as a transcription 
factor. To date, placental TLRs have not been described in 
the rat placenta. In humans, TLR4 has been demonstrated 
in first trimester trophoblast cell lines,34 and first trimester 
and term syncytiotrophoblasts.15–17 Importantly, TLR4 has 
been reported in Hofbauer cells (placental macrophages) in 
preterm human placenta from gestations with a history of 
chorioamnionitis.35 Thus, maternal inflammatory mediators 
may evoke placental responses in trophoblast or macrophage 
cells via a TLR pathway. In this study, TLR4 was detected 
in both the preterm and near-term rat placenta, although the 
level of expression was not affected by lipopolysaccharide 
exposure at 6 hours. However, TLR4 pathway activation in 
the rat placenta resulted in increased nuclear phosphorylated 
NFκB. Notably, after 30 minutes of lipopolysaccharide 
exposure, there was increased phosphorylated NFκB in the 
nucleus of both preterm and near-term placental explants, 
consistent with lipopolysaccharide-mediated activation of 
the TLR4 pathway. This suggests that the TLR4 NFκB 
pathway is activated in response to lipopolysaccharide in 
the rat placenta and is possibly one potential mechanism by 
which the cytokine response is induced.
Contrary to expectations, 30 minutes of lipopolysaccharide 
exposure resulted in greater nuclear translocation of 
phosphorylated NFκB in the near-term compared with 
preterm placenta, although this did not result in a more robust 
TNF-α and IL-6 cytokine response at a later gestational 
age. Notably, after nuclear NFκB acts as a transcription 
factor and promotes production of TNF-α and IL-6 mRNA, 
there are a number of post-transcriptional mechanisms that 
provide rate-limiting controls on the amount of cytokine that 
is translated and released.36,37 TNF-α and IL-6 induction is 
regulated post-transcriptionally by mRNA binding proteins 
and microRNAs.38 Adenylate-uridylate-rich elements in 
the 3′UTR of IL-6 and TNF-α mRNA dictate mRNA 
degradation.33,37 Perhaps e20 placenta has an enhanced 
ability to regulate the production of proinflammatory 
cytokines under infection conditions via post-transcriptional 
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mechanisms. Additional experiments are required to dissect 
the transcriptional and post-transcriptional mechanisms 
through which NFκB may promote placental production 
of TNF-α and IL-6 cytokines, and clarify the divergent 
NFκB and cytokine responses in the preterm and near-term 
placenta.
There are many proinflammatory mediators and signaling 
pathways that may potentially lead to placental or fetal 
inflammation and eventually to fetal neurologic injury. 
A clear limitation of this study is the narrow focus on 
proinflammatory cytokines and their induction via the NFκB 
pathway. Further research is warranted to clarify the role of 
the other inflammatory mediators (eg, other interleukins, 
and nitrergic or prostanoid pathways) that likely contribute 
to placental and fetal inflammation and possibly to the 
development of fetal neurologic injury.
In our ex vivo rat placental explant model, viability 
of placental tissue was maintained for up to 6 hours, 
as assessed by lactate dehydrogenase measurement in 
tissue and supernatant from lipopolysaccharide-treated 
and lipopolysaccharide-nontreated explants at e16 and 
e20. Lactate dehydrogenase is a cytoplasmic enzyme, 
and minimal alteration in its concentration in the media 
further substantiates that placental membrane integrity 
was preserved during the experiments. In support of 
our findings, lactate dehydrogenase release from human 
placental explants treated with lipopolysaccharide (1 µg/
mL) remained unchanged for 24 hours, indicating that the 
lipopolysaccharide concentration used was not toxic to the 
explants.39 Consistent with these findings, any release of 
cytokines in our model was likely due to lipopolysaccharide 
induction rather than tissue damage. Higher placental basal 
lactate dehydrogenase release at e20 versus e16 was probably 
dependent on gestational age.
In summary, we have established an ex vivo model of 
placental cytokine production with lipopolysaccharide 
induction of NFκB. In vivo rat studies have shown that 
pretreatment with the anti-inflammatory cytokine, IL-10, 
significantly reduced the size of the brain lesions and 
blocks the exacerbating effect of IL-1β on brain lesions.40,41 
 Antioxidants, such as N-acetyl-cysteine, have also been shown 
to inhibit proinflammatory cytokine release in human fetal 
membranes,42 and prevent upstream events leading to NFκB 
activation in cell culture.43 Moreover, maternal N-acetyl-
cysteine administration blocks placental and amniotic fluid 
cytokine responses to maternal lipopolysaccharide injection, 
and prevents the increase in fetal brain IL-6.19 This explant 
model may be used to examine the role of the placental 
cytokine cascade in the efficacy of these anti-inflammatory 
therapeutic strategies.
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